U.S. market Closed. Opens in 1 day 2 hours 14 minutes

ONCT | Oncternal Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue785.00K1.49M4.32M3.38M2.42MN/AN/AN/AN/AN/AN/AN/A14.74M60.61M14.73M13.53M7.13M7.50M3.78M1.87MN/AN/AN/AN/AN/A
Cost of Revenue29.75M179.00K169.00K12.00M10.16MN/AN/AN/AN/AN/AN/AN/A1.05M768.00K1.29M649.00K621.00K773.00K1.57MN/AN/AN/AN/AN/AN/A
Gross Profit-28.97M1.31M4.15M-8.62M-7.73MN/AN/AN/AN/AN/AN/AN/A13.68M59.84M13.44M12.88M6.50M6.73M2.21M1.87MN/AN/AN/AN/AN/A
Operating Expenses12.75M44.95M31.37M17.54M15.02M39.06M30.66M25.93M21.84M30.35MN/AN/A47.38M45.91M60.09M67.36M52.01M45.25M40.77M25.16MN/AN/AN/AN/AN/A
Selling, General & Admin12.75M13.46M11.60M8.37M7.29M9.39M9.19M8.71M8.23M9.48M11.28M10.85MN/A17.42M27.75M23.11MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development29.75M32.98M24.09M12.54M10.16M29.67M21.47M17.23M13.61M20.87M32.32M38.89M31.94M28.50M32.34M44.26M38.51M33.90M30.92M17.95M10.47M9.29M5.92M2.68M518.00K
Other Operating Expenses-29.75M-1.49M-4.32M-3.38M-2.42M641.00KN/AN/AN/AN/AN/AN/A15.44MN/AN/AN/A13.50M11.35M9.85M7.21MN/AN/AN/AN/AN/A
Operating Income-41.71M-44.95M-31.37M-17.54M-33.11M-39.06M-30.66M-25.93M-21.84M-30.35M-43.60M-49.73M-33.69M13.93M-46.65M-54.48M-45.50M-38.52M-38.56M-23.29M-14.34M-12.02M-8.15M-3.96M-819.00K
Other Expenses / Income2.23M777.00K33.00K317.00K-1.08M641.00K216.00K8.21M3.14M-9.06M1.49M-19.00K398.00K1.36M159.00KN/AN/AN/AN/AN/A143.00KN/AN/AN/AN/A
Before Tax Income-39.48M-44.17M-31.33M-17.23M-34.19M-38.42M-30.44M-17.72M-18.70M-39.41M-42.11M-49.75M-33.29M15.29M-46.49MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-41.71M-777.00K-33.00K-16.00K-18.28M641.00KN/AN/AN/AN/AN/A-8.82MN/AN/A-238.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-39.48M-43.39M-31.30M-17.21M-15.91M-38.42M-30.44M-17.72M-18.70M-39.41M-42.11M-27.07M-33.29M15.29M-46.26M-51.78M-40.36M-35.51M-36.84M-22.35M-14.19M-11.87M-8.06M-3.81M-750.00K
Interest ExpensesN/A-702.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding2.94M2.63M2.47M1.02M516.45K3.34M2.49M2.08M2.01M1.17M900.82K897.27K819.42K555.35K520.22K518.59K499.14K445.00K371.18K328.47K110.50K110.50K110.68K110.50K110.50K
Diluted Shares Outstanding2.94M2.63M2.47M1.02M516.45K3.34M2.49M2.08M2.11M1.17M900.82K897.27K819.42K555.35K520.22K518.59K499.14K445.00K371.18K343.75K110.50K110.50K110.68K110.50K110.50K
EBITDA2.23M-44.95M-31.37M-17.54M-14.83M-39.01M-30.39M-25.91M-21.80M-30.25M-43.22M-48.98M-32.25M16.87M-44.71M-50.22M-45.26M-40.52M-37.14M-22.93M-14.12M-11.69M-8.15M-3.88M-774.00K
EBITDA Margin284.71%-3,016.58%-726.91%-519.76%-611.63%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-218.83%27.83%-303.52%-371.22%-635.12%-539.88%-981.97%-1,228.07%0.00%0.00%0.00%0.00%0.00%
EBIT-81.19M-44.87M-31.33M-17.23M-34.19M-37.78M-30.44M-17.72M-18.70M-39.41M-42.11M-35.90M-33.29M15.29M-46.49M-51.78M-40.36M-35.51M-36.84M-22.35M-14.19M-11.87M-8.06M-3.81M-750.00K
EBIT Margin-10,343.06%-3,011.54%-726.14%-510.37%-1,409.81%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-225.89%25.23%-315.64%-382.76%-566.36%-473.15%-974.06%-1,197.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙